Longevity Stock Exchange Recommendation
TOTAL SCORE: 10
Score
A1 (Feasibility increased by continuance of pandemic): 0
A2 (Necessity increased by covid pandemic): 0
A3 (political viability): 0
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): 0
B2 (Relevance to general goal of biomedical healthy life extension): +1
C1 (Market readiness applicability): +1
C2 (Project readiness): -1
C3 (Move to market readiness): +1
D1 (Actionability): +1
D2 (Degree of measurability): +1
D3 (Degree of leveraging cross-sector inputs): +1
D4 (Awareness of international context): +1
D5 (Resourcefulness): +1
D6 (Reorganisation): +1
E (Disruptiveness): +1
F (Dividends - does the recommendation aid in social activity and inclusivity?): +1
RECOMMENDATION SUMMARY
A Longevity stock exchange marks the end of the journey toward a fully-fledged, multifarious global commercial industry, when Health Longevity has become a quantifiable product, and the platforms for various types of Longevity company have been established, along with a Longevity index fund, and we see the emergence of a new type of digital asset platform stock exchange.
Such an entity would be the first of its kind in the world, and if it is supported by key government officials, and integrated with the Longevity startups ecosystem, it could easily secure the position as a leading, progressive Longevity financial hub. The ultimate goal of this project would be the deployment of a Longevity Industry index (similar to the NASDAQ-Composite, which serves as an indicator of expectations on the growth of the USA tech industry).
Alternative Stock Exchanges are usually associated with uprising wealth within regional boundaries. They facilitate brokers to do their business in the selling of shares to companies and vice versa with heightened efficiency. It enhances companies’ access to capital and the chance to also increase their views and their public image. All savvy businesses can increase the power of stock sharing to expand and enhance their companies. While advantages to financial and regulatory costs are connected with being listed on the alternative stock exchange, the benefits far outdo the disadvantage. A Longevity based stock exchange would provide further access to capital, profile enhancement, control maintenance, reduction of the cost of capital and increases the ability to attract more investment.
However, the establishment of such a stock exchange should involve the use of modern, sophisticated approaches to human-centered validation of Longevity therapeutics and technologies (including biomarkers of human Longevity, and the other platforms for human experimentation and validation discussed previously) as a necessary prerequisite for companies to be listed on such exchanges.
The first nation to establish a specialized Longevity Stock exchange will have effectively created something resembling a perpetual motion machine for the further growth of its national Longevity Industry, having built an engine for providing its companies with sufficient investment and accelerating the market-readiness of their technologies, products and services. The nation that establishes marketplaces for both shares in publicly-traded Longevity companies and financial instruments and derivatives built as a second layer upon its Longevity Industry would be capable of attracting several trillions of potential wealth that is currently inaccessible and locked away.
Current financial products' levels of sophistication are limited by status-quo financial and legal frameworks, but new technologies platforms and frameworks have the potential to allow for the creation of truly innovative financial products and systems. In our view, the ideal solution for designing novel financial instruments and products is to establish a new specialized financial marketplace in the form of a specialized stock exchange with a formal license, to serve as the base and launching pad for a wider variety of financial instruments and systems tied to the Longevity Industry.
Eventually, this could take the form of a Longevity Industry financial index, similar to the NASDAQ composite, which would represent the current state of the Longevity Industry in one particular region. We suspect that these types of frameworks will most likely emerge in regions that have recognition within the broader international financial community, stability, and a prospective domestic Longevity Industry, yet which are large enough to encompass the behavior of the Longevity Industry globally.
At the present time, we see London and the US as the most prospective regions in this regard, although Switzerland, Singapore and Hong Kong have fairly strong prospects as well. A Longevity Stock Exchange provides increased liquidity, which in turn would enables greater flexibility and a greater leverage for the further growth of the companies listed on the exchange, and as such, greater opportunities for the advancement of the full-scope Longevity Industry as a whole globally. More broadly, Singapore as a smart city state currently has the smallest gap between Health-Adjusted Life Expectancy (HALE) and life expectancy, and is very well known for rapidly implementing frameworks for the balanced strategic support of innovative startups and technologies, and for quickly attracting foreign talents for highly focused industry development, which may serve as an efficient basis and ecosystem not only for accelerated technology innovation, but also financial innovations as well.
Specialized stock exchanges are nothing new. Currently, for example, investors can dig into about 50 major commodity markets worldwide. Those include markets for soft commodities such as wheat, coffee, cocoa and other agricultural products, and markets for commodities that are mined, such as gold and oil. NASDAQ fits that profile as well; it was created as a stock exchange for IT-companies and is currently the home of tech-oriented stocks. Several examples of the successful implementation of innovative approaches to legal and regulatory frameworks, administration and management exist, which lay good groundwork for structuring the right approach to establishing a Longevity Stock Exchange, including the Alternative Investment Market (AIM), a subsidiary of the London Stock Exchange, which gives medium-sized companies opportunities to be publicly listed in an intermediate way, providing them with a framework for raising tens of millions of pounds (rather than just several millions at best) by opening up access to the broader conservative investment community, which prefer to deal only with tradeable, highly liquid assets.
Establishing a Longevity Stock Exchange would require the public listing of at least 100 Longevity-focused companies to create good enough diversity and potential volume for trading. Thereafter, the more advances there are in Longevity, the more even the most conservative investors will want to invest. By that point they will have been well advised that Longevity is an industry like no other. It is by such means that increased global Longevity will be transformed from a threat into an opportunity.
Score
A1 (Feasibility increased by continuance of pandemic): 0
A2 (Necessity increased by covid pandemic): 0
A3 (political viability): 0
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): 0
B2 (Relevance to general goal of biomedical healthy life extension): +1
C1 (Market readiness applicability): +1
C2 (Project readiness): -1
C3 (Move to market readiness): +1
D1 (Actionability): +1
D2 (Degree of measurability): +1
D3 (Degree of leveraging cross-sector inputs): +1
D4 (Awareness of international context): +1
D5 (Resourcefulness): +1
D6 (Reorganisation): +1
E (Disruptiveness): +1
F (Dividends - does the recommendation aid in social activity and inclusivity?): +1
RECOMMENDATION SUMMARY
A Longevity stock exchange marks the end of the journey toward a fully-fledged, multifarious global commercial industry, when Health Longevity has become a quantifiable product, and the platforms for various types of Longevity company have been established, along with a Longevity index fund, and we see the emergence of a new type of digital asset platform stock exchange.
Such an entity would be the first of its kind in the world, and if it is supported by key government officials, and integrated with the Longevity startups ecosystem, it could easily secure the position as a leading, progressive Longevity financial hub. The ultimate goal of this project would be the deployment of a Longevity Industry index (similar to the NASDAQ-Composite, which serves as an indicator of expectations on the growth of the USA tech industry).
Alternative Stock Exchanges are usually associated with uprising wealth within regional boundaries. They facilitate brokers to do their business in the selling of shares to companies and vice versa with heightened efficiency. It enhances companies’ access to capital and the chance to also increase their views and their public image. All savvy businesses can increase the power of stock sharing to expand and enhance their companies. While advantages to financial and regulatory costs are connected with being listed on the alternative stock exchange, the benefits far outdo the disadvantage. A Longevity based stock exchange would provide further access to capital, profile enhancement, control maintenance, reduction of the cost of capital and increases the ability to attract more investment.
However, the establishment of such a stock exchange should involve the use of modern, sophisticated approaches to human-centered validation of Longevity therapeutics and technologies (including biomarkers of human Longevity, and the other platforms for human experimentation and validation discussed previously) as a necessary prerequisite for companies to be listed on such exchanges.
The first nation to establish a specialized Longevity Stock exchange will have effectively created something resembling a perpetual motion machine for the further growth of its national Longevity Industry, having built an engine for providing its companies with sufficient investment and accelerating the market-readiness of their technologies, products and services. The nation that establishes marketplaces for both shares in publicly-traded Longevity companies and financial instruments and derivatives built as a second layer upon its Longevity Industry would be capable of attracting several trillions of potential wealth that is currently inaccessible and locked away.
Current financial products' levels of sophistication are limited by status-quo financial and legal frameworks, but new technologies platforms and frameworks have the potential to allow for the creation of truly innovative financial products and systems. In our view, the ideal solution for designing novel financial instruments and products is to establish a new specialized financial marketplace in the form of a specialized stock exchange with a formal license, to serve as the base and launching pad for a wider variety of financial instruments and systems tied to the Longevity Industry.
Eventually, this could take the form of a Longevity Industry financial index, similar to the NASDAQ composite, which would represent the current state of the Longevity Industry in one particular region. We suspect that these types of frameworks will most likely emerge in regions that have recognition within the broader international financial community, stability, and a prospective domestic Longevity Industry, yet which are large enough to encompass the behavior of the Longevity Industry globally.
At the present time, we see London and the US as the most prospective regions in this regard, although Switzerland, Singapore and Hong Kong have fairly strong prospects as well. A Longevity Stock Exchange provides increased liquidity, which in turn would enables greater flexibility and a greater leverage for the further growth of the companies listed on the exchange, and as such, greater opportunities for the advancement of the full-scope Longevity Industry as a whole globally. More broadly, Singapore as a smart city state currently has the smallest gap between Health-Adjusted Life Expectancy (HALE) and life expectancy, and is very well known for rapidly implementing frameworks for the balanced strategic support of innovative startups and technologies, and for quickly attracting foreign talents for highly focused industry development, which may serve as an efficient basis and ecosystem not only for accelerated technology innovation, but also financial innovations as well.
Specialized stock exchanges are nothing new. Currently, for example, investors can dig into about 50 major commodity markets worldwide. Those include markets for soft commodities such as wheat, coffee, cocoa and other agricultural products, and markets for commodities that are mined, such as gold and oil. NASDAQ fits that profile as well; it was created as a stock exchange for IT-companies and is currently the home of tech-oriented stocks. Several examples of the successful implementation of innovative approaches to legal and regulatory frameworks, administration and management exist, which lay good groundwork for structuring the right approach to establishing a Longevity Stock Exchange, including the Alternative Investment Market (AIM), a subsidiary of the London Stock Exchange, which gives medium-sized companies opportunities to be publicly listed in an intermediate way, providing them with a framework for raising tens of millions of pounds (rather than just several millions at best) by opening up access to the broader conservative investment community, which prefer to deal only with tradeable, highly liquid assets.
Establishing a Longevity Stock Exchange would require the public listing of at least 100 Longevity-focused companies to create good enough diversity and potential volume for trading. Thereafter, the more advances there are in Longevity, the more even the most conservative investors will want to invest. By that point they will have been well advised that Longevity is an industry like no other. It is by such means that increased global Longevity will be transformed from a threat into an opportunity.